Oliver Sum-Ping, MD, a Clinical Associate Professor of Psychiatry and Sleep Medicine at Stanford Medicine who wasnt affiliated with the research told Healthline, The results suggest substantial potential for the role of these medications for at least mitigating OSA. The SURMOUNT-OSA trial was a multi-center, randomized, double-blind, placebo-controlled trial conducted with 469 patients, all of whom had OSA
Hair Loss Hair loss or thinning while on methotrexate is slow and is reversed once you stop taking the medication
While sulfur burps are usually mild and self-limiting, persistent symptoms can prompt medication discontinuation or avoidable dose adjustments
In addition, clinical risk factors such as dyslipidemia, hypertension, and hyperglycemia should be addressed more aggressively
More info
Its trailing Price/Earnings (P/E) ratio is ~13.3, while its forward P/E is just ~8.2